---
title: "Bioinformatics"
excerpt: "Bioinformatics <br/><img src='/images/Bioinformatics.png'>"
collection: portfolio
---

Background
In my journey through bioinformatics, I’ve come to appreciate the complexity and challenges inherent in modern biological research, especially when it comes to understanding cellular diversity, gene expression, and genome structure. By leveraging cutting-edge technologies like single-cell transcriptomics and ATAC-seq chromatin accessibility profiling, we gain a deeper understanding of the mechanisms at play at the single-cell level, which is crucial for solving metabolic and immune-related issues.
<br/>
Single-cell transcriptomics allows us to capture the diversity of gene expression within individual cells, offering a more precise view of cellular behavior in both physiological and pathological contexts. This technology is especially valuable for studying metabolic disorders and immune responses, as it helps us track the roles of various cell types throughout disease progression.
<br/>
On the other hand, ATAC-seq provides insights into chromatin accessibility, shedding light on the regulatory mechanisms that govern gene expression. Changes in chromatin accessibility are key drivers of cellular function, particularly in immune cell activation and metabolic regulation. The dynamic changes in chromatin structure serve as the foundation for determining cell behavior. By combining these technologies, we can better understand immune cell differentiation, metabolic pathway regulation, and their roles in disease, ultimately contributing to the development of new therapeutic strategies.
<br/><br/>

# Bioinformatics and COVID-19
Scientific Question: Exploring the material basis and therapeutic mechanisms of natural drugs through bioinformatics.<br/><br/>
Background: COVID-19, caused by the SARS-CoV-2 virus, emerged as a global pandemic in late 2019, leading to significant public health, social, and economic disruptions. The virus primarily spreads through respiratory droplets, and its symptoms range from mild respiratory issues to severe pneumonia and death. The rapid mutations of the virus have resulted in multiple variants, complicating efforts to control the pandemic.<br/><br/>
Bioinformatics has played a crucial role in the response to COVID-19, particularly in the areas of viral genome analysis, vaccine development, drug discovery, and clinical data interpretation. Through sequencing the SARS-CoV-2 genome, bioinformatics tools allowed for the rapid identification and tracking of viral variants. Additionally, bioinformatics methods enabled the design of vaccines and the virtual screening of potential antiviral drugs. By analyzing clinical and genomic data, bioinformatics also facilitated early detection of disease biomarkers and improved understanding of the virus’s behavior and transmission patterns.<br/><br/>
**Flow Chart**<img src="/images/Bioinformatics/huashi.png"><br/><br/>
(1) Ann Palliat Med. 2021 Apr;10(4):3864-3895.<br/><br/>
(2) Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology. 2021,23(02):358-384.<br/><br/>
The flow chart of the database establishment. The flowchart explains the collection of crude drug medicinal materials, the acquisition of all ingredients, active ingredients, and the analysis of active compounds properties.<img src="/images/Bioinformatics/drug-database.png"><br/>
The scatter diagram of component properties, including oral bioavailability (OB), molecular weight (MW), hydrogen bond donor (Hdon), hydrogen bond acceptor (Hacc), blood-brain barrier (BBB), drug-likeness (DL), drug half-life (HL), Caco-2 permeability (Caco-2), fractional water accessible surface area (FASA−), and the partition coefficient between octanol and water (AlogP).<img src="/images/Bioinformatics/component.png"><br/> 
The potential mechanism diagram of HSBDF on SARS-CoV-2 involving potential therapeutic pathways of HSBDF: AMPK signaling pathway, Arachidonic acid metabolism, NF-kappa B signaling pathway, Serotonergic synapse, Renin-angiotensin system, and Renin secretion.<img src="/images/Bioinformatics/mechanism.png"><br/> <br/>
And the overall histogram of GO biological and KEGG analysis.<img src="/images/Bioinformatics/GO1.png"><br/> 
<img src="/images/Bioinformatics/GO2.png"><br/> 
<img src="/images/Bioinformatics/GO3.png"><br/> 
<img src="/images/Bioinformatics/GO4.png"><br/> 
<img src="/images/Bioinformatics/GO5.png"><br/> <br/>
Molecule docking for key component and COVID-19 related protein. <img src="/images/Bioinformatics/molecule-docking1.jpg"><br/>
<img src="/images/Bioinformatics/molecule-docking2.jpg"><br/><br/>

# Bioinformatics and Metabolism
Scientific Question: Analysis of Medication Rules and Pharmacological Mechanisms of Diabetes MellitusTreatment Based on Data Mining and Bioinformatics<br/><br/>
Backgroud: Diabetes and obesity are two major global health challenges that have become increasingly prevalent in modern societies. Both conditions are closely linked to metabolic dysfunctions, often sharing common risk factors such as insulin resistance, inflammation, and impaired glucose metabolism. Type 2 diabetes, the most common form, is characterized by a chronic state of hyperglycemia, while obesity is a multifactorial disease, primarily driven by an imbalance between energy intake and expenditure. These conditions significantly contribute to the global burden of chronic diseases, leading to complications such as cardiovascular diseases, kidney failure, and neurological impairments. Understanding the molecular mechanisms underlying these diseases is crucial for developing targeted therapeutic strategies.<br/>
Bioinformatics, with its powerful computational tools, plays a pivotal role in unraveling the complex biological mechanisms involved in diabetes, obesity, and other metabolic disorders. By leveraging large-scale genomic, transcriptomic, and proteomic data, bioinformatics allows for the identification of genetic variants, biomarkers, and key molecular pathways that contribute to disease pathogenesis. In particular, technologies like Bulk RNA-seq, single-cell RNA-seq and ATAC-seq chromatin accessibility profiling enable detailed insights into cell-specific gene expression and epigenetic modifications in metabolic tissues. Bioinformatics also facilitates the integration of multi-omics data to better understand the interactions between genes, proteins, and metabolites. This integrated approach offers promising avenues for discovering new therapeutic targets and advancing personalized medicine in the treatment of diabetes and obesity.
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2022,24(02):597-609.<br/><br/>
**Flow Chart**<img src="/images/Bioinformatics/metabolism-flow.png"><br/><br/>
**molecule Docking**<img src="/images/Bioinformatics/molecule-docking3.jpg"><br/><br/>

# Bioinformatics and Skin ILCs
Scientific Question: How RORγt and Gata3 regulate Skin ILC2s<br/><br/>
Backgroud: Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that lack rearranged antigen receptors. Cutaneous ILCs, mainly ILC2s, are essential for sustaining tissue equilibrium, contributing to physiological and pathological roles. Here, this review explores the characteristics of cutaneous ILCs in different conditions. This review highlights the role of skin ILCs in maintaining tissue homeostasis by regulating microbiome balance. It examines how their dysfunction can lead to inflammatory skin diseases like atopic dermatitis, psoriasis, and melanoma. ILC-related factors contribute to physiological functions and their implications in various pathological conditions, potentially highlighting key areas for future research. 
Dev Cell. 2024 Jul 22;59(14):1809-1823.e6<br/>
**Graphical Abstract**<br/><img src='/images/developmental-cell-abstract.png'><br/><br/>
**ILCs-ATAC**<br/><img src='/images/Bioinformatics/skin-ATACseq.jpg'><br/><br/>
**ILCs-ATAC2**<br/><img src='/images/Bioinformatics/skin-ATACseq2.jpg'><br/><br/>
**ILCs-scRNA**<br/><img src='/images/Bioinformatics/skin-scseq.jpg'><br/><br/>

# Bioinformatics and Inflammatory Bowel Disease 
Scientific Question: How do genetic, epigenetic, and microbiome-associated factors interact to influence the immune response in the development and progression of Inflammatory Bowel Disease, and can bioinformatics approaches identify novel biomarkers for personalized treatment strategies and ILCs?
Backgroud: Inflammatory Bowel Disease (IBD), which includes Crohn's disease and ulcerative colitis, is a group of chronic inflammatory conditions of the gastrointestinal tract. The pathogenesis of IBD is complex, involving interactions between genetic susceptibility, environmental factors, and the gut microbiome. Despite extensive research, the precise molecular mechanisms remain poorly understood. Advances in bioinformatics, particularly in the analysis of high-dimensional omics data (genomics, transcriptomics, metagenomics, and proteomics), have opened new avenues to understand the underlying molecular causes of IBD. Techniques such as single-cell RNA sequencing, whole-genome sequencing, and microbiome analysis enable the identification of specific biomarkers, cellular changes, and microbial dysbiosis associated with IBD. Bioinformatics tools also allow for the integration of multi-omics datasets, providing a more comprehensive view of how genetic, epigenetic, and environmental factors converge to promote inflammation and disease progression.
**Il18 Tissue expression (RNA)** <img src="/images/Bolg-Il18/il18-2.jpg"><br/><br/>
**Il18 Tissue expression (Protein)** <img src="/images/Bolg-Il18/il18-3.jpg"><br/><br/>
**Il18 Normal Human Intestine expression** <img src="/images/Bolg-Il18/il18-4.jpg"><br/><br/>
**Il18 and Il18r expression for human intestine single cell rna-seq** <img src="/images/Bolg-Il18/il18-5.jpg"><br/><br/>
**Il18 and Il18r expression for human intestine single cell rna-seq, GSE124880, Mice, CD45+ Immune Cell in SiLP and PP, Immunity** <img src="/images/Bolg-Il18/il18-6.jpg"><br/> <img src="/images/Bolg-Il18/il18-7.jpg"><br/><br/>
**Il18 and Il18r expression for Epithelium** <img src="/images/Bolg-Il18/il18-8.jpg"><br/><br/>
**Il18 and Il18r expression for IEL** <img src="/images/Bolg-Il18/il18-9.jpg"><br/><br/>
**ATAC-seq GSE116093 IGV**<br/><img src="/images/GSE116093-IGV.png"><br/><br/>
**Il18 DO and Il18 D14, Spatial transcriptomics** <img src="/images/IL18-D0.png"> <img src="/images/IL18-D14.png"><br/><br/>
**ILC3 DO and D14, Spatial transcriptomics** <img src="/images/ILC3-D0.png"> <img src="/images/ILC3-D14.png"><br/><br/>

<br/>
Different time point for DSS (IBD), data from our own sequence.
**DSS result** <img src="/images/Bioinformatics/DSS.jpg"><br/><br/>
**DSS single cell RNA-seq** from mcie colon for Lamina propria and epithelium, almost 300,000 cells. <br/><img src="/images/Bioinformatics/DSS-sc.jpg"><br/>



